Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Enrollment Forms Article
This is a selection made from among articles on Drug Treatment Enrollment Forms. For a permanent link to this article, or to bookmark it for future reading, click here.
Drug Addiction Disease
from:Drug addiction is a disease. There’s no doubt about that. In fact experts say that drug addiction is more of a brain disease than anything else. Scientific advances have offered amazing insights into how the brain works and what drugs do to the way the brain functions. Luckily, however, this disease is treatable and curable.
Although drug use initially is voluntary once an addiction develops, that control is markedly changed. Imaging studies have shown specific abnormalities in the brains of some, but not all, addicted individuals. While scientific advancements in the understanding of addiction have occurred at unprecedented speed in recent years, unanswered questions remain that highlight the need for further research to better define the neurobiological processes involved in addiction.
Recent studies have increased our knowledge of how drugs affect gene expression and brain circuitry, and how these factors affect human behavior. They have shed new light on the relationship between drug abuse and mental illness, and the roles played by heredity, age, and other factors in increased vulnerability to addiction. New knowledge from future research will guide new strategies and change the way clinicians approach the prevention and treatment of addiction.
When we approach drug addiction as a disease instead of as a choice, the treatment options are greatly increased. We can research what areas of the brain are affected and find the best methods to address that affliction specifically. Doctors treat cancer, diabetes, and other disease like this, drug addiction should be no different.
Viewing drug addiction as a disease can also help researchers delve further into genetic propensity to drug use and addiction. That means we will know whether or not drug and alcohol use is linked to our family history and will be able to tackle the problem before it actually becomes a problem.
There are medications available to treat withdrawal symptoms when a person stops using drugs, but when drug addiction is researched as a disease, scientists will be able to come up with new medications that could actually prevent drug use from becoming an addiction. Similar to medications that make alcoholics sick when they drink.
There are all sorts of diseases in the world. There’s no doubt about it that drug addiction is one of them. We need to start looking at it in that way and then taking the appropriate steps to treat drug addiction just as we would another disease like cancer or Alzheimer’s.
Drug Treatment Enrollment Forms Specific links
Drug Treatment Enrollment Forms News
Global Human Vaccines Industry
NEW YORK, May 16, 2012 /PRNewswire/ --Â Reportlinker.com announces that a new market research report is available in its catalogue: Global Human Vaccines Industry http://www.reportlinker.com/p092575/Global-Human-Vaccines-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and ...
Read more...Celsion Announces ThermoDox(R) Commercial Supply Agreement With Hisun
LAWRENCEVILLE, NJ-- - Celsion Corporation , a leading oncology drug development company, announced today that it has signed a long term commercial supply agreement with Zhejiang Hisun Pharmaceutical Co. ...
Read more...Groundbreaking Alzheimer's Disease Prevention Trial Announced
PHOENIX, May 15, 2012 /PRNewswire/ -- In collaboration with the National Institutes of Health (NIH), Banner Alzheimer's Institute (BAI), University of Antioquia in Colombia and Genentech, a member of the ...
Read more...MediciNova Reports First Quarter 2012 Results
SAN DIEGO -- MediciNova, Inc. a biopharmaceutical company traded on the NASDAQ Global Market and the Jasdaq Market of the Osaka Securities Exchange (Code Number: 4875), announced financial results for ...
Read more...Q1 10-Q, Development On-Track
FluoroPharma (FPMI) filed their 10-Q for the first quarter ending March 31, 2012 on May 15th.
Read more...FPMI - Q1 10-Q, Development On-Track
By Brian Marckx, CFAQ1 2012 10-Q FiledFluoroPharma (OTC BB:FPMI) filed their 10-Q for the first quarter ending March 31, 2012 on May 15th. Operating expenses continue to be inline with our expectations ...
Read more...First Patient Treated in U.S. Clinical Study of Cohera Medical's TissuGlu® Surgical Adhesive
PITTSBURGH, May 1, 2012 /PRNewswire/ -- Cohera Medical, Inc.®, a leading innovator and developer of absorbable surgical adhesives and sealants, today announced the treatment of the first patient in a prospective, ...
Read more...Celldex Announces Plans to Release Topline Results from the EMERGE Study in Advanced Breast Cancer
Celldex Therapeutics, Inc. today announced that interim, topline results of the Phase 2b EMERGE study of CDX-011 in patients with advanced breast cancer will be presented in a webcast on May 23, 2012.
Read more...EpiCept Reports First Quarter 2012 Operating and Financial Results
Regulatory News:
Read more...QLT Announces First Quarter 2012 Results
VANCOUVER, British Columbia -- QLT Inc. ("QLT" or the "Company") is a biotechnology company dedicated to the development and commercialization of innovative ocular products that address ...
Read more...